Doxorubicin-SMCC is a pharmaceutical intermediate used in the manufacturing of antibody-drug conjugates (ADCs). This compound consists of a doxorubicin core linked to a maleimide-containing crosslinker, enabling targeted conjugation to antibodies.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 400647-59-8
Sulfo-SPDB
Pharmaceutical intermediate for antibody-drug conjugate
3'-O-Methylguanosine 5'-(dihydrogen phosphate)
Pharmaceutical intermediate for nucleotide synthesis
4-[2-((6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-ylsulfanyl)thiazole-4-yl]-1-methyl-pyridiniumchloride monohydrochloride
Pharmaceutical intermediate for ceftolozane
5'-O-DMT-N2-DMF-dG
Nucleoside protecting group intermediate
3-Fluorobenzotrichloride
dye, pesticide, pharmaceutical intermediate
4-[(2,5-dioxopyrrol-1-yl)methyl]-N-[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]cyclohexane-1-carboxamide
OTQOQHVWNBKSGU-SAJDXUNTSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C6CCC(CC6)CN7C(=O)C=CC7=O)O